Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myelomaRong Fan, Kim De Veirman|Journal for ImmunoTherapy of Cancer|2023Cited by 19
Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid LeukemiaRong Fan, Kim De Veirman|Blood Cancer Journal|2023Cited by 15